Candel Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $29k | 5.6k | 5.10 |
| 2025-06-30 | $49k | 9.6k | 5.06 |
| 2025-03-31 | $12k | 2.1k | 5.65 |
| 2024-12-31 | $13k | 1.5k | 8.68 |
| 2024-09-30 | $19k | 2.7k | 6.93 |
| 2024-06-30 | $7.8k | 1.3k | 6.20 |
| 2024-03-31 | $5.8k | 3.7k | 1.58 |
| 2023-09-30 | $8.0k | 8.6k | 0.92 |
| 2023-06-30 | $10k | 8.3k | 1.26 |
| 2023-03-31 | $9.0k | 6.6k | 1.37 |
| 2022-12-31 | $13k | 7.2k | 1.80 |
| 2022-09-30 | $13k | 4.1k | 3.14 |
| 2022-06-30 | $4.0k | 1.2k | 3.28 |
| 2022-03-31 | $0 | 54 | 0.00 |